Related Experiment Video
Updated: Nov 3, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review
Nathália Alves Araújo de Almeida1, Camilla Rodrigues de Almeida Ribeiro1, Jéssica Vasques Raposo1
1Laboratory of Molecular Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 21040-360 Rio de Janeiro, Brazil.
Abstract:
Immunotherapy has been shown to be highly effective in some types of cancer caused by viruses. Gene therapy involves insertion or modification of a therapeutic gene, to correct for inappropriate gene products that cause/may cause diseases. Both these types of therapy have been used as alternative ways to avoid cancers caused by oncoviruses. In this review, we summarize recent studies on immunotherapy and gene therapy including the topics of oncolytic immunotherapy, immune checkpoint inhibitors, gene replacement, antisense oligonucleotides, RNA interference, clustered regularly interspaced short palindromic repeats Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based gene editing, transcription activator-like effector nucleases (TALENs) and custom treatment for Epstein-Barr virus, human T-lymphotropic virus 1, hepatitis B virus, human papillomavirus, hepatitis C virus, herpesvirus associated with Kaposi's sarcoma, Merkel cell polyomavirus, and cytomegalovirus.
Insights
Immunotherapy and gene therapy offer promising alternatives for treating virus-associated cancers. This review explores advanced techniques like CRISPR and immune checkpoint inhibitors for oncovirus-driven malignancies.
Area of Science:
- Oncology
- Virology
- Immunology
- Gene Therapy
Background:
- Oncoviruses are a significant cause of various human cancers.
- Traditional cancer treatments may have limitations for virus-associated malignancies.
- Immunotherapy and gene therapy present novel therapeutic strategies.
Purpose of the Study:
- To review recent advancements in immunotherapy and gene therapy for oncovirus-related cancers.
- To highlight specific therapeutic approaches and targeted viruses.
Main Methods:
- Review of current scientific literature on immunotherapy and gene therapy.
- Focus on oncolytic immunotherapy and immune checkpoint inhibitors.
- Exploration of gene editing tools like CRISPR and TALENs, and other gene-based therapies.
Main Results:
- Immunotherapy, including immune checkpoint inhibitors, shows efficacy in certain virus-driven cancers.
- Gene therapy approaches such as gene replacement and RNA interference offer potential.
- Gene editing technologies like CRISPR and TALENs provide precise therapeutic interventions.
- Specific viral targets include Epstein-Barr virus, HPV, HBV, and others.
Conclusions:
- Immunotherapy and gene therapy are powerful tools against oncovirus-induced cancers.
- A range of innovative techniques are being developed for targeted cancer treatment.
- Further research is warranted to optimize these therapies for clinical application.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Gene Therapy
Mechanisms of Retrovirus-induced Cancers

